Abrilumab

DB15076InvestigationalProtein Based Therapies

Abrilumab is under investigation in clinical trial NCT01290042 (Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.).

Mechanism: Pharmacologically active on Integrin alpha-4 and Integrin beta-7
Curator reviewed
Code names: AMG 181

Resolves to

Compound

UNIIY9UQ37XT2TCAS1342290-43-0

Targets

P13612ITGA4P26010ITGB7

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

4Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Abrilumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account